| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.36 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |